Uterine Mapping for Lymph Node Metastasis in Endometrial Cancer: A Multicenter Retrospective Cohort Study
Journal of Obstetrics and Gynaecology Research · 2026
DOI: 10.1111/jog.70180 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Şahin Kaan Baydemir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Ankara Etlik City Hospital, University of Health Sciences, Ankara, Turkey. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Lymphatic Metastasis, Uterus, Lymph Nodes. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Aim
To evaluate the association between uterine tumor localization and lymph node metastasis (LNM) in endometrial cancer through pathological uterine mapping.
Methods
This multicenter retrospective cohort study included 427 patients with endometrial carcinoma who underwent total hysterectomy, bilateral salpingo‐oophorectomy, and systematic lymphadenectomy. Tumor localization was classified based on a six‐site pathological mapping model: isolated lower uterine segment (LUS), LUS + corpus, corpus‐only, corpus+fundus, fundus‐only, and total uterine cavity. LNM patterns and pathological features were compared across sites. Logistic regression was used to determine independent predictors of LNM.
Results
The highest LNM rates were observed in tumors involving the LUS + corpus (37.0%) and total uterine cavity (32.4%), whereas the lowest rate was seen in corpus‐only tumors (10.2%) ( p < 0.001). Tumors in high‐risk sites featured significantly higher rates of deep myometrial invasion, substantial LVSI, and high‐grade histology. In multivariate analysis, substantial LVSI (OR: 9.2, p < 0.001), any LUS involvement (OR: 2.6, p = 0.001), aggressive histology (OR: 2.1, p = 0.017), and BMI (OR: 1.08, p = 0.025) independently predicted LNM.
Conclusions
Pathological uterine mapping reveals that LUS involvement is an independent risk factor for lymphatic dissemination in endometrial cancer. Tumor site classification may enhance preoperative risk stratification and guide individualized surgical strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Ankara Etlik City Hospital, University of Health Sciences, Ankara, Turkey.
- Obstetrics and Gynecology Department, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Türkiye.
- Department of Gynecologic Oncology, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Türkiye.
ORCID-Profile: Şahin Kaan Baydemir, Hande Nur Öncü, Oğuz Kaan Köksal
Zitieren
APA
Baydemir, Ş. K., Öncü, H. N., Başpınar, Z., Köksal, O. K., Hanedan, C., & Korkmaz, V. (2026). Uterine Mapping for Lymph Node Metastasis in Endometrial Cancer: A Multicenter Retrospective Cohort Study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70180
Vancouver
Baydemir ŞK, Öncü HN, Başpınar Z, Köksal OK, Hanedan C, Korkmaz V. Uterine Mapping for Lymph Node Metastasis in Endometrial Cancer: A Multicenter Retrospective Cohort Study. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70180
BibTeX
@article{Baydemir2026,
author = {Baydemir, Şahin Kaan and Öncü, Hande Nur and Başpınar, Zeynep and Köksal, Oğuz Kaan and Hanedan, Candost and Korkmaz, Vakkas},
title = {Uterine Mapping for Lymph Node Metastasis in Endometrial Cancer: A Multicenter Retrospective Cohort Study},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
doi = {10.1111/jog.70180}
}
EUVIMED